Fischer A B, Johnson M A, Roberts E F. "Method for the Synthesis of 2-((4-(2-Methylpiperidin-1-yl)-1,2,5-thiadiazol-3-yl)oxy)acetic acid" [P]. US Patent, US 10938644 B2, 2023-09-05.
发明人胡光,张德明,高志强. "A Process for Preparing High-Purity 2-((4-(2-Methylpiperidin-1-yl)-1,2,5-thiadiazol-3-yl)oxy)acetic acid" [P]. 中国发明专利, 专利号 CN 117734057 A, 授权公告日 2025-02-22.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Environ. Sci. Technol., 2018, 1567, 356-365.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Methods, 2020, 1154, (5), 484-510.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of 2-((4-(2-Methylpiperidin-1-yl)-1,2,5-thiadiazol-3-yl)oxy)acetic acid Using HRMS and NMR". Anal. Chem., 2015, 99, 9700-9727.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Food Chem., 2022, 2023, (3), 3537-3557.